CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,125 | -25.1% | 250,000 | 0.0% | 0.00% | – |
| Q2 2023 | $384,500 | -37.4% | 250,000 | -50.0% | 0.00% | – |
| Q1 2023 | $614,250 | +116.9% | 500,000 | +100.0% | 0.00% | – |
| Q4 2022 | $283,250 | +3.4% | 250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $274,000 | -93.8% | 250,000 | -93.2% | 0.00% | – |
| Q2 2022 | $4,415,000 | -24.5% | 3,655,000 | +7.3% | 0.00% | – |
| Q1 2022 | $5,851,000 | +3.4% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,661,000 | +7.6% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,263,000 | -4.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,486,000 | +3.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,322,000 | +11.8% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2020 | $4,760,000 | +24.9% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,812,000 | +7.0% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,564,000 | -39.9% | 3,405,000 | -46.8% | 0.00% | -100.0% |
| Q1 2020 | $5,929,000 | – | 6,405,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,115,000 | $4,708,428 | 0.71% |
| ZAZOVE ASSOCIATES LLC | 5,455,000 | $6,306 | 0.58% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,076,000 | $4,644,575 | 0.29% |
| MACKAY SHIELDS LLC | 6,287,000 | $7,123,996 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,994,000 | $18,201,172 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,997,000 | $10,397,505 | 0.11% |
| Teton Advisors, Inc. | 350,000 | $404,604 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,264,000 | $3,759,802 | 0.10% |
| Calamos Wealth Management LLC | 384,000 | $436,992 | 0.03% |
| GABELLI FUNDS LLC | 3,000,000 | $3,468,030 | 0.03% |